ArticleScientific reports2026
Cloning, expression and characterisation of short-chain dehydrogenase/reductase SDR12 (A0A7I5E7J1) from a parasitic nematode Haemonchus contortus.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Short-chain dehydrogenases/reductases (SDRs) play a crucial role in xenobiotic and eobiotic metabolism in all organisms. In the parasitic nematode Haemonchus contortus, SDRs represent potential contributors to drug resistance and potential drug targets. Among them, Hco_sdr12 (WormBaseAcc: HCON_0049110) seemed to be the most interesting as its constitutive expression was higher in all developmental stages of H. contortus from the benzimidazole-resistant strain in comparison to the drug-susceptible strain. Moreover, Hco_sdr12 was inducible by exposure of H. contortus adult females with the anthelmintic drug flubendazole (FLU). With an aim to know more about this enzyme, Hco_SDR12 (UniprotAcc: A0A7I5E7J1) was cloned, purified and characterised. The corresponding gene was cloned into the pET22b(+) vector system, the protein was overexpressed in E. coli and purified by Ni-affinity chromatography. The various xenobiotic and eobiotic compounds, including FLU, were tested as potential substrates of Hco_SDR12. Although this enzyme did not reduce FLU, significant reductase activities toward many other substrates were found with a preference for NADPH as a coenzyme. Glyceraldehyde, metyrapone and ketoprofen were used for kinetic studies. According to bioinformatic analysis, Hco_SDR12 shares the highest similarity with hydroxysteroid dehydrogenase-like protein 2, which may indicate its involvement in lipid metabolism. Even though Hco_SDR12 cannot deactivate FLU, it can deactivate other xenobiotics with a carbonyl group. Its higher expression might help nematodes to protect themselves against reactive compounds and to gain energy from lipids more effectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.